Actelion aims to improve people's lives by creating innovative medicines that make a real difference.
In order to achieve this and maximize the potential of our innovative discovery, development and commercialization efforts, we are preparing for transformational growth.
We are currently putting processes and infrastructure in place to rapidly advance our novel chemical entities currently in late stage development, to become innovative medicines for patients in areas of high unmet medical need.
We are also focusing on attracting and retaining the best people in the industry who identify with our innovative and results-driven approach. This fosters an enthusiastic, stimulating environment for employees, and for company growth.
Actelion has already recorded very impressive growth: as this chart shows, we have rapidly increased our number of employees worldwide.
Not only does Actelion grow in staffing numbers, but also geographically. Actelion today has over 30 national affiliates, and we continue to expand and invest in emerging markets, such as, Poland, Russia, Mexico, China and other countries.
New buildings at headquarters
Actelion’s headquarters is also expanding to be able to meet the needs of our people.
The architecture of our new buildings is both functional and symbolic of the innovative spirit of our company. Transparent and communication-friendly buildings contribute to fostering a team oriented approach and the creativity of our workforce, and help to attract talented people in a competitive job market.
The unique architecture of the Actelion center contributes to creating an attractive place to work for our employees, and adds value for all our stakeholders.
